Dynex Capital, Inc. (DX)
NYSEReal EstateReit - MortgageSnapshot 2026-09-04
$12.90+0.55%
Close 2026-09-04 · 1-day change
NYSEReal EstateReit - MortgageSnapshot 2026-09-04
QuarterlyIQ Insights · DX
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 8 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $13 DX trades at 11× p/e, in line with its 9.7× p/e peer median — but our blended $11 fair value sits below the price. We hold it with medium confidence: this sector is better valued on book value or cash flow than the earnings/sales multiple shown here. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| ddm gordon | 12M | $41.28 | — | — | TTM | high |
| graham number | 12M | $19.08 | — | — | TTM | high |
| Peer P/FCF | 12M | $8.60 | 8.1 | 1.06 | TTM | high |
| Peer P/FFO | 12M | $5.46 | 9.7 | 0.56 | TTM | high |
| Peer P/S | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
No fragility gates fired.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $7.00 |
| 1.8 |
| 3.97 |
| TTM |
| high |
| PEG | 12M | $8.38 | 7.4 | 1.14 | TTM | high |
| residual income | 12M | $14.46 | — | — | TTM | high |
| triangulated | 12M | $10.94 | 9.7 | 1.12 | Triangulated | high |
| Peer P/FCF | 3Y | $13.08 | 8.1 | 1.61 | Hist. CAGR(prov.) | low |
| Peer P/S | 3Y | $2.13 | 1.8 | 1.21 | Analyst | low |
| PEG | 3Y | $5.90 | 7.4 | 0.80 | Analyst | low |
| Peer P/FCF | 5Y | $17.30 | 8.1 | 2.13 | Hist. CAGR(prov.) | medium |
| PEG | 5Y | $2.67 | 7.4 | 0.36 | Analyst | medium |